• Publications
  • Influence
Lymphoproliferative disorders in individuals with chronic hepatitis b and C in the Turkish population
TLDR
The association with malignant lymphoproliferative disorders in chronic viral hepatitis seems to be high as compared to that occurring in individuals with non‐alcoholic fatty liver disease. Expand
A real world multicenter retrospective study on extramedullary disease from Balkan Myeloma Study Group and Barcelona University: analysis of parameters that improve outcome
TLDR
This cohort demonstrated that extramedullary disease benefits from front-line autologous stem cell transplantation and extramingullary plasmacytoma differs from paraosseous involvement in terms of rate and duration of response, with even worse outcomes when detected at relapse, constituting an unmet clinical need. Expand
Treatment of hypertriglyceridemia-induced acute pancreatitis with plasmapheresis
TLDR
A case with type I familial hyperlipidemia who presented with hypertriglyceridemia-induced acute pancreatitis, which did not respond to conservative treatment but only abated after plasmapheresis is presented. Expand
PET with Fluorodeoxyglucose F 18/Computed Tomography as a Staging Tool in Multiple Myeloma.
TLDR
This review comprises a comprehensive overview of PET with fluorodeoxyglucose F 18/CT imaging in combination with other convenient imaging procedures, and attempts at standardization with emphasis on post-therapy findings in patients with myeloma. Expand
Ibrutinib As a Promising Treatment for Pulmonary Complications Due to Refractory Chronic Graft Versus Host Disease
TLDR
This study suggests that ibrutinib is a safe and effective agent that reduces steroid requirements and stabilizes lung function in patients with bronchiolitis obliterans as a manifestation of cGVHD, and adds to a growing body of evidence for ibrUTinib's use in cGV HD. Expand
Donor Lymphocyte Infusions for Relapsed Hematological Malignancies after Allogeneic Hematopoietic Stem Cell Transplantation: Single Center Experience
TLDR
This study assessed the risk factors for GVHD and transplant-related mortality (TRM) as well as disease outcomes according to the reason for DLI in patients who received DLI after allo-HSCT and could not demonstrate the higher CD3+ cell dose of DLI associated with an increased risk of GV HD. Expand
...
1
2
3
4
...